Exscalate4CoV project
Exscalate4CoV (acronym E4C) is an EU-funded project that was selected after the emergency Call of expression of interest that the European Commission issued on 31 January. The project will receive a 3 million EUR of EU funding in the next 18 months. The E4C team uses supercomputers in the search of therapies (small molecule drugs) against SARS-CoV-2 by complementing the classical trial and error clinical approach and possible experimentation in patients.
To supplement the E4C compound pipeline, the project invites organisations to submit proposals for screening of their compounds for efficacy profiling on the E4C Biology platforms.
Full criteria and conditions are defined in the “Drug-Box” submission portal on the E4C website – www.exscalate4cov.eu.